ARTICLE | Company News
RBO, EPMN vaccine deal
January 9, 2002 8:00 AM UTC
Rhein Biotech (NMarkt:RBO) entered into a research agreement with Epimmune (EPMN) to evaluate EPMN's PADRE synthetic peptide immunostimulants in combination with several RBO vaccines based on recombin...